Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: analysis of national insurance claims
Bih-Ru Wang,1,2,* Yuh-Lih Chang,1,2,* Tzeng-Ji Chen,3,4 Jen-Hwey Chiu,5,6 Jing Chong Wu,7 Min-Shan Wu,1 Chia-Lin Chou,1 Yueh-Ching Chou1,2,81Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan; 2Department and Institute of Pharmacology, National Yang-Ming University, Taipei, Tai...
Main Authors: | Wang BR, Chang YL, Chen TJ, Chiu JH, Wu JC, Wu MS, Chou CL, Chou YC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-05-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/coprescription-of-chinese-herbal-medicine-and-western-medication-among-a16711 |
Similar Items
-
Trends in Coprescription Among Taiwanese Children from 2002 to 2012
by: Tou SI, et al.
Published: (2023-12-01) -
Adverse events with quetiapine and clarithromycin coprescription: A population‐based retrospective cohort study
by: Kevin Yau, et al.
Published: (2023-06-01) -
Association between benzodiazepine coprescription and mortality in people on opioid replacement therapy: a population-based cohort study
by: Catriona Matheson, et al.
Published: (2024-03-01) -
Prescription profile of Chinese herbal products containing coumestrol, genestein, and/or daidzein among female users: an analysis of national health insurance data in Taiwan between 1997 and 2007
by: Wu Chien-Tung, et al.
Published: (2012-10-01) -
Prediction of auto-insurance claims
by: Zeng, Zhuang An
Published: (2018)